Replies to post #14 on Taysha Gene Therapies Inc (TSHA)

[subslover]

aysha Drops on Stock Offering
October 26 2022 - 08:18AM
TipRanks
Alert
Print
Share On Facebook
Gene therapy company Taysha Gene Therapies’ (NASDAQ:TSHA) shares are tanking in the pre-market session today on the announcement of an underwritten public offering of $30 million. All the shares on offer are being sold by Taysha and underwriters will have the option to acquire an additional 15% of shares at the same terms over the next 30 days. The development comes fresh on the heels of Taysha announcing a major deal with Astellas Pharma that will see the latter making a $50 million strategic investment in Taysha for a 15% stake.
https://www.tipranks.com/news/taysha-drops-on-stock-offering?utm_source=advfn.com&utm_medium=referral